Searched over 200M research papers
10 papers analyzed
These studies suggest that atherosclerotic lesions in the abdominal aorta are associated with asymptomatic coronary heart disease, aortic enlargement, aneurysmal dilation, and increased morbidity in chronic heart failure patients.
20 papers analyzed
Atherosclerosis in the abdominal aorta is a common condition often detected incidentally during abdominal CT scans. Studies have shown that these atherosclerotic lesions are highly associated with coronary heart disease, even in asymptomatic adults. For instance, a study involving 1,494 asymptomatic adults found that abdominal atherosclerotic lesions with stenosis less than 25% were significantly associated with coronary stenosis, with higher odds ratios for more severe stenosis. This highlights the importance of recognizing and managing these lesions to prevent potential cardiovascular events.
Atherosclerotic plaque formation in the abdominal aorta is closely linked to aortic enlargement. Research on cadaver aortas has demonstrated that plaque area is a primary predictor of abdominal aortic size, with increased plaque area correlating with aortic enlargement and decreased media thickness. This relationship suggests that atherosclerosis not only contributes to plaque buildup but also to structural changes in the aorta, which may predispose individuals to aneurysmal dilation.
Hemodynamic factors play a crucial role in the distribution of atherosclerotic plaques in the abdominal aorta. Plaques tend to form in areas where flow separation occurs, such as the anterior inferior wall of the abdominal aorta, influenced by the branching angles of the renal arteries. This supports the theory that blood flow dynamics significantly contribute to the development and severity of atherosclerotic lesions.
Atherosclerosis of the abdominal aorta has significant prognostic implications for patients with heart failure. A study involving 355 heart failure patients found that those with atherosclerotic disease of the abdominal aorta and its branches had worse outcomes, including longer hospital stays and higher admission rates. Although the presence of atherosclerosis was not independently related to overall prognosis, its association with increased morbidity underscores the need for careful monitoring and management in these patients.
TIMP4 (Tissue Inhibitor of Metalloproteinase 4) has been identified as a protective factor against atherosclerotic plaque deposition in the abdominal aorta. Research on mice lacking TIMP4 showed higher plaque density in the abdominal aorta despite lower plasma cholesterol levels, indicating that TIMP4 helps prevent cholesterol accumulation and plaque formation by maintaining extracellular matrix integrity and inhibiting smooth muscle cell transdifferentiation. This finding suggests potential therapeutic targets for preventing atherosclerosis in the abdominal aorta.
The detection and management of atherosclerotic lesions in the abdominal aorta are crucial for preventing cardiovascular diseases. Understanding the hemodynamic influences and the role of specific proteins like TIMP4 can aid in developing targeted therapies. Additionally, recognizing the prognostic implications in heart failure patients can improve patient outcomes through tailored treatment strategies.
In conclusion, atherosclerosis in the abdominal aorta is a significant health concern with implications for coronary heart disease and heart failure. Continued research and improved diagnostic techniques are essential for early detection and effective management of this condition.
Most relevant research papers on this topic